My scientific career started during my undergraduate degree, in Brazil. While working on my Bachelors of Pharmacy degree, I fell in love with science when joining the Vaccine Laboratory of Federal University of Alfenas, in 2011. In the Vaccine Laboratory, I developed my honours undergraduate project, supervised by Dr. Luiz Felipe Leomil Coelho, in which I implement an immunization protocol against Pseudomonas aeruginosa using a new nanoparticle-based vaccine that was developed by our group.

​

On the fourth year of my undergraduate degree, I was awarded a highly competitive scholarship funded by the Brazilian government, Science Without Borders (2012), which fully funded a one-year exchange program in the Cumming School of Medicine (CSM), at the University of Calgary, Alberta, Canada. During this exchange program, I worked in the lab of Dr. Shawn Lewenza, leading two different mutagenesis and high-throughput gene expression screening projects, utilizing Pseudomonas strains, for the identification of biosensor genes for environmental pollutants found in waste water of the Alberta tar sands.

​

I was later moved back to Calgary to complete a MSc in Microbiology, in the Lewenza lab (2014). For my MSc project I implemented different in vitro and in vivo technics to characterize the antibiofilm and antivirulence properties of exopolysaccharide (EPS)-inhibitor small molecules against P. aeruginosa. 

​

Shortly after my MSc, I joined Dr. Arrieta’s lab as a Research Assistant (2017), where I managed and oversaw multiple research projects in her lab. As I was still passionate with academia and given my excellent performance and eagerness to continue learning, I was offered a PhD position in her lab (2019). During my time in the Arrieta lab I participated in different research and clinical projects investigating the role of the intestinal microbiome in the development of immune-mediated and metabolic diseases. My PhD thesis project focused on characterizing the ecological and immunoregulatory role of intestinal fungi, and how early-life antibiotic intervention influence airway inflammation later in life.

​

Now, I have joined the laboratory of Dr. William Agace (2024), at Copenhagen University. My current project further dives into my passion of host-microbiome interactions, exploring the importance of microbiome-fibroblast crosstalk in intestinal immune development and regulation.